The Social Impact of Novartis medicines: Two Case Studies from South Africa and Kenya

This study offers insights into the following topics:

– The quantification and monetization of Novartis’ global social impact by translating health improvements from its medicines into economic value. 
– The connection between better health and national prosperity, demonstrating how healthier populations contribute to GDP through both paid and unpaid work. 
– A new framework for viewing health as an investment, emphasizing its importance for resilient economic growth and social progress.